The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure - Wikidata - wikimedia - TriplyDB

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

http://www.wikidata.org/entity/Q28169100

about

Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm Anticoagulation versus placebo for heart failure in sinus rhythm Anticoagulation versus placebo for heart failure in sinus rhythm Organ-specific responses to circulatory disturbances in heart failure: new insights Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm The Benefit and Safety of Aspirin for Primary Prevention of Ischemic Stroke: A Meta-Analysis of Randomized Trials Anticoagulation in Heart Failure: a Review Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm Anticoagulation for heart failure in sinus rhythm Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors Antithrombotic therapy in heart failure Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis Cardioembolic Stroke.Empirical anticoagulation for patients in sinus rhythm at high risk of ischaemic stroke: A review of current literature.Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves.Clinical evidence review: best practice heart failure.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Antithrombotics in heart failure.Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study.Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses Stroke and anticoagulation in heart failure without atrial fibrillation: from risk to opportunity.Left ventricular dysfunction in the haemodialysis population.Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Antithrombotic therapy in heart failure Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.Treatment for heart failure: good news and bad.Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry Out-patient management of chronic heart failure.Anticoagulation in Heart Failure: a Review.Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?Heart failure in East Asia Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease.Warfarin and aspirin in patients with heart failure and sinus rhythm.

P2860

Q24185800-8A47D518-82EF-4880-A86B-BE5BACF2124E Q24197822-8CE70FB7-BDF0-47E1-9C6C-C9241CD341A2 Q24202686-3A865C20-6855-412C-8151-771598B4FFCD Q26822738-3DC2358F-CCA3-4BF7-B4ED-9D0D79C49C65 Q26822837-1AAF5242-0587-414D-B97D-7A09E64ECE6B Q28066973-F3D0D18B-6EC9-4B96-8F27-E4D33733902F Q28087068-F414AB7B-9AF4-46CF-A5E6-3C9300F4D535 Q28168872-B53C4A55-25C6-4426-8F73-0105EA09F316 Q28191116-3F80A4DF-CF0F-4AF2-8637-E74C491A38C7 Q28191123-3C015848-A395-4061-88FD-822E732D152B Q28192714-51D88D28-7FB5-4545-84B0-342292F409FD Q28200166-7CBACF32-68BD-494F-B22F-BAA26B99CE39 Q28218279-07651E2D-2DF5-4A37-BF08-B6C0EE8171DD Q28218636-AEC063B4-2E50-4AF6-89C8-022F18484093 Q28484769-01F6CD67-C3BA-470E-A48F-46DD8B190699 Q30238631-0CA5558E-9B19-440D-983C-1FECEF332A57 Q33721188-E523B598-A7D2-4B02-BC02-6FBF1C2BF725 Q33768602-77255AF3-F3A0-4F08-A5B2-3D77991A5AF9 Q34132273-890663A3-F1E5-40D9-9F15-A51A1A738863 Q34276182-90C18259-CB02-4535-8AB9-564405D7B8CD Q34648874-BE7351C2-A25B-4473-AF50-7B9EE71FFD18 Q34675426-2A2E1C42-4E25-446B-85F8-4FBE149149EE Q34830023-6DBA4445-A962-40BC-9B5B-3638304DD8DA Q34965626-7A2B2381-71A8-45B9-B1BB-2B6DBA6E7A85 Q35454452-805F0D0F-F893-4A78-937F-B03306137A8C Q35485247-C57BA169-D114-446E-AC81-BC4B233221F9 Q35554746-B5CE3D67-3348-408A-A902-475EB2F4EF68 Q35573726-5456CD6C-452F-4076-AA5C-CD5C5C9CE120 Q35752598-86A37EEF-5446-4CDD-B2CC-67D2C83F78F9 Q35828163-C6269E59-7E41-4A65-BA17-9320E406B265 Q35970469-EAD179D9-FFA9-45B8-8077-57EC554C10DF Q36058743-D8002363-5975-45E9-99A4-8DEDD93D16BE Q36133383-80A21FE1-73C9-4851-9F35-0ABE6247AD88 Q36236408-AA86F85A-0D8C-40D6-A586-74C1B7F5BC1B Q36249926-E9992718-5495-4CC2-82CF-127D97536A69 Q36381170-66E5E16D-2852-40C8-B3F1-8C802D1ED813 Q36543429-073AA4E9-EBB6-4528-B027-367E70779D11 Q36928510-CA77177C-0E40-40D8-AD96-16C126201350 Q37041279-68EC3C0E-BC6A-4FD8-852F-688F4C4A7B62 Q37045277-6BAA746F-C37B-4440-AAB1-3DCB2C2794C5

P2860

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

http://www.wikidata.org/entity/Q28169100

description

2004 nî lūn-bûn

@nan

2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

The Warfarin/Aspirin Study in ...... or patients with heart failure

@ast

The Warfarin/Aspirin Study in ...... or patients with heart failure

@en

The Warfarin/Aspirin Study in ...... or patients with heart failure

@nl

type

label

The Warfarin/Aspirin Study in ...... or patients with heart failure

@ast

The Warfarin/Aspirin Study in ...... or patients with heart failure

@en

The Warfarin/Aspirin Study in ...... or patients with heart failure

@nl

prefLabel

The Warfarin/Aspirin Study in ...... or patients with heart failure

@ast

The Warfarin/Aspirin Study in ...... or patients with heart failure

@en

The Warfarin/Aspirin Study in ...... or patients with heart failure

@nl

P1433

Q28169100-0EEC0FA6-DB3A-40F0-93C9-5F4311AB88B5

P1476

Q28169100-29876B0F-03A2-4E1C-BE28-917389BA271A

P2093

Q28169100-1AB99331-AE8A-43A8-84CE-8F1A5F7B832B

Q28169100-3098ABFF-D279-4642-81DC-9F9345A01CA2

Q28169100-36757D38-B25E-4980-BABA-CAF0DC60A8FD

Q28169100-6FBD3F99-5ECB-433B-8DF8-E32676953B1A

Q28169100-9C45CF20-6C9E-4384-B895-990D9EC45D67

Q28169100-AB51C3A8-5C1D-4983-95F9-E570ED1B51C7

Q28169100-B5F0D439-BAD0-4F34-9F9A-480002CDBA13

Q28169100-E22E61D4-0EF6-4A8D-889D-0AAE51174F7F

Q28169100-F7DA670D-ACCF-4C5D-80C5-DA38385A56D2

P304

Q28169100-41632D30-C00F-4C56-BFB6-6BC54E5BE384

P31

Q28169100-8BED6BBC-C38C-416B-842F-717511705B78

P3181

Q28169100-1B2F06D3-1B63-4D77-9FCC-5510DE098A0D

P356

Q28169100-59D8291F-3967-4477-BEE6-07D0FFA64D3E

P407

Q28169100-3BE6166B-F002-4151-AC6B-9A5D10EE7D2A

P433

Q28169100-0E68F182-6968-4BE8-839C-CA7842E1E13B

P478

Q28169100-9D4EF11F-A897-4CF0-940B-1BB01D558571

P50

Q28169100-4944A881-F99D-414E-8859-6A9FE55BA6F6

P577

Q28169100-AC7239BD-7FBC-46EB-9B60-52D2BD448477

P698

Q28169100-5E9DF484-9ECA-42BE-8994-3CD9C14DD463

P921

Q28169100-1582AAB9-72D9-4E03-8106-21881A11D7A9

Q28169100-60216524-E978-4E44-BCCD-BECF5AAF7D61

Q28169100-8E735B4D-EE6A-4AB5-882F-EBC0486248F6

P3181

P356

J.AHJ.2004.03.010

P1433

American Heart Journal

P1476

The Warfarin/Aspirin Study in ...... or patients with heart failure

@en

P2093

Adele Trainer

http://www.w3.org/2001/XMLSchema#string

C Bulpitt

http://www.w3.org/2001/XMLSchema#string

C Prentice

http://www.w3.org/2001/XMLSchema#string

G Sutton

http://www.w3.org/2001/XMLSchema#string

I Findlay

http://www.w3.org/2001/XMLSchema#string

I Ford

http://www.w3.org/2001/XMLSchema#string

P A Poole-Wilson

http://www.w3.org/2001/XMLSchema#string

R Falk

http://www.w3.org/2001/XMLSchema#string

S Jafri

http://www.w3.org/2001/XMLSchema#string

P304

157-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5055737

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.AHJ.2004.03.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15215806

http://www.w3.org/2001/XMLSchema#string

P921